| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683 |
| filingDate |
2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f076f5941c4591dc69de1be85390f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4847c058255f88754466e8141051b9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aca23dced546edfc1550db2fa95768b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6351be83e123873fe54b3dac9f020a |
| publicationDate |
2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015272971-A1 |
| titleOfInvention |
Use of glycerophosphoinositols for the treatment of septic shock |
| abstract |
The present invention refers to glycerophosphoinositols (GPIs) and derivatives thereof for use in the treatment of pathologies related to a Lipopolysaccharide (LPS)-activated tissue-factor (TF) activity, as pathologies induced by high bacteremia, i.e. septic shock. |
| priorityDate |
2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |